Follow
Mehmet Sofuoglu
Mehmet Sofuoglu
Verified email at yale.edu
Title
Cited by
Cited by
Year
The effect of cannabis compared with alcohol on driving
RA Sewell, J Poling, M Sofuoglu
American journal on addictions 18 (3), 185-193, 2009
4982009
Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
M Sofuoglu, PS Portoghese, AE Takemori
Journal of Pharmacology and Experimental Therapeutics 257 (2), 676-680, 1991
4491991
Cognitive enhancement as a treatment for drug addictions
M Sofuoglu, EE DeVito, AJ Waters, KM Carroll
Neuropharmacology 64, 452-463, 2013
3462013
Stress decreases the ability to resist smoking and potentiates smoking intensity and reward
SA McKee, R Sinha, AH Weinberger, M Sofuoglu, ELR Harrison, ...
Journal of psychopharmacology 25 (4), 490-502, 2011
3272011
Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans.
M Sofuoglu, S Dudish-Poulsen, D Nelson, PR Pentel, DK Hatsukami
Experimental and clinical psychopharmacology 7 (3), 274, 1999
3141999
Neuroscience of behavioral and pharmacological treatments for addictions
MN Potenza, M Sofuoglu, KM Carroll, BJ Rounsaville
Neuron 69 (4), 695-712, 2011
2772011
Norepinephrine and stimulant addiction
M Sofuoglu, RA Sewell
Addiction biology 14 (2), 119-129, 2009
2312009
Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population
J Poling, A Oliveto, N Petry, M Sofuoglu, K Gonsai, G Gonzalez, B Martell, ...
Archives of general psychiatry 63 (2), 219-228, 2006
2262006
Cognitive effects of nicotine: recent progress
G Valentine, M Sofuoglu
Current neuropharmacology 16 (4), 403-414, 2018
2142018
The drug effects questionnaire: psychometric support across three drug types
ME Morean, H de Wit, AC King, M Sofuoglu, SY Rueger, SS O’Malley
Psychopharmacology 227, 177-192, 2013
2022013
Cognitive enhancement as a pharmacotherapy target for stimulant addiction
M Sofuoglu
Addiction 105 (1), 38-48, 2010
1902010
Novel approaches to the treatment of cocaine addiction
M Sofuoglu, TR Kosten
CNS drugs 19, 13-25, 2005
1662005
Treatment outcome predictors for cocaine dependence
J Poling, TR Kosten, M Sofuoglu
The American journal of drug and alcohol abuse 33 (2), 191-206, 2007
1532007
Role of progesterone in nicotine addiction: evidence from initiation to relapse.
WJ Lynch, M Sofuoglu
Experimental and clinical psychopharmacology 18 (6), 451, 2010
1502010
Tiagabine increases cocaine‐free urines in cocaine‐dependent methadone‐treated patients: results of a randomized pilot study
G Gonzalez, K Sevarino, M Sofuoglu, J Poling, A Oliveto, K Gonsai, ...
Addiction 98 (11), 1625-1632, 2003
1412003
Effects of progesterone treatment on smoked cocaine response in women
M Sofuoglu, DA Babb, DK Hatsukami
Pharmacology Biochemistry and Behavior 72 (1-2), 431-435, 2002
1392002
Sex steroid hormones, stress response, and drug craving in cocaine-dependent women: implications for relapse susceptibility.
R Sinha, H Fox, KI Hong, M Sofuoglu, PT Morgan, KT Bergquist
Experimental and clinical psychopharmacology 15 (5), 445, 2007
1362007
Effects of progesterone treatment on cocaine responses in male and female cocaine users
M Sofuoglu, E Mitchell, TR Kosten
Pharmacology Biochemistry and Behavior 78 (4), 699-705, 2004
1322004
The impact of cigarette smoking on stimulant addiction
AH Weinberger, M Sofuoglu
The American journal of drug and alcohol abuse 35 (1), 12-17, 2009
1312009
Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine
M Sofuoglu, AI Herman, H Nadim, P Jatlow
Neuropsychopharmacology 37 (6), 1509-1516, 2012
1302012
The system can't perform the operation now. Try again later.
Articles 1–20